Validea’s guru fundamental report for AMGEN, INC. (AMGN) shows it rates highest using the Multi-Factor Investor model based on Pim van Vliet’s strategy. AMGN is a large-cap growth stock in the Biotechnology & Drugs industry with a rating of 81%. The stock meets some criteria of the strategy but fails to meet others. Pim van Vliet’s research shows that low volatility stocks can outperform high volatility ones with less risk. Validea is an investment research service that follows the strategies of investment legends like Warren Buffett and Benjamin Graham.

Read more at Nasdaq: Validea Detailed Fundamental Analysis – AMGN